Sygnature Discovery

JULY 31, 2023

Founded in 2011, NuChem Sciences delivers expert integrated and standalone discovery solutions across medicinal, synthetic, scale-up, process and computational chemistry, as well as DMPK, in vitro biology and in vivo pharmacology.

Computational Chemistry 52

Computational Chemistry Science Pharmaceutical Companies Clinical Trials 52

Sygnature Discovery

MAY 9, 2022

They have established multiple collaborations with renowned pharmaceutical companies and successfully developed the AI software platforms Makya™ for new drug design and Spaya™ for synthesis planning.

Computational Chemistry 52

Computational Chemistry Pharmaceutical Companies Science Pharmaceuticals 52

Practical Cheminformatics

DECEMBER 7, 2023

A recent editorial by Dean Brown in J Med Chem and follow-up posts by Keith Hornberger and Derek Lowe prompted me to think about how we train computational chemists and cheminformaticians for careers in drug discovery. It also brought to mind some unique differences between how computational chemistry is practiced in biotech and pharma.

Computational Chemistry 90

Computational Chemistry Pharmacokinetics Pharmaceutical Companies Drugs 90

The Pharma Data

NOVEMBER 15, 2020

” Arthur Oubrie, Chief Scientific Officer of Lead Pharma, added: “This is the second project we partner with one of the largest pharmaceutical companies under our Discover, Design and Deliver platform. ” About Immune Mediated Diseases. A wide range of human diseases is driven by deregulated immune function.

Small Molecule 52

Small Molecule Licensing Licensing Disease 52

DrugBank

JUNE 27, 2024

Opportunities in Drug Repurposing There is great potential for drug repurposing to unlock treatments for rare and neglected diseases, where traditional drug development is too costly. Pharma companies are often rich with valuable chemical libraries and expertise, while academics bring emerging disease biology knowledge.

Drugs 71

Drugs Pharma Companies Computational Chemistry Clinical Trials 71

LifeSciVC

APRIL 27, 2023

The premise at the time was that putting computational chemistry in the primary position for new molecule ideation would upend the drug discovery paradigm. set up a “virtual project team,” leverage Schrödinger scientists to lead computational chemistry, and do all the wet work at CROs. It did just that.

Small Molecule 52

Small Molecule Computational Chemistry Engineering Clinical Development 52